Gerard Serfati insider trades: Kyto Biopharma (KBPH) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Gerard reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 11, 2006 | KBPH | ↓ Sell | 4,500,000 | $0.50 | $2.3M | Direct | Jan 13, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Gerard Serfati's insider trades
Gerard Serfati is a 10% owner of Kyto Biopharma (KBPH). Since Jan 11, 2006, Gerard has reported no open-market purchases and 1 sale worth $2.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KBPH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.